首页 | 本学科首页   官方微博 | 高级检索  
   检索      

痰热清注射液联合纳洛酮对老年慢性呼吸衰竭并发肺性脑病患者临床疗效的影响
引用本文:唐燕玉,刘 刚,龙翔宇,陈红梅,冯小玲,郑家琼.痰热清注射液联合纳洛酮对老年慢性呼吸衰竭并发肺性脑病患者临床疗效的影响[J].现代生物医学进展,2017,17(12):2332-2334.
作者姓名:唐燕玉  刘 刚  龙翔宇  陈红梅  冯小玲  郑家琼
作者单位:四川大学华西广安医院 呼吸科 四川 广安 638000;第三军医大学第二附属医院 呼吸科 重庆 400037;广安市人民医院 肿瘤科 四川 广安 638000
基金项目:四川省卫生厅科研项目(120275)
摘    要:目的:探讨痰热清注射液联合纳洛酮对老年慢性呼吸衰竭并发肺性脑病患者临床疗效的影响。方法:选取我院呼吸科收治的慢性呼吸衰竭并发肺性脑病患者60例,随机分为治疗组和对照组,每组30例。对照组给予加痰热清注射液治疗,治疗组在对照组治疗基础上联合纳洛酮注射液治疗。治疗结束后,比较治疗前后两组患者动脉血气分析结果、血清BNP(脑钠肽)、SOD(超氧化物歧化酶)、MDA(丙二醛)水平及临床疗效。结果:与治疗前相比,两组患者治疗后的血清BNP、MDA水平降低,SOD水平升高(P0.05),PaO_2水平升高,PaCO_2水平下降(P0.05);与对照组比较,治疗组总有效率较高,BNP、MDA水平较低,SOD水平较高(P0.05),PaO_2水平较高,PaCO_2水平较低(P0.05)。结论:痰热清注射液联合纳洛酮治疗老年慢性呼吸衰竭并发肺性脑病临床疗效好,推测其机制与降低血清BNP、MDA及升高血清SOD水平有关。

关 键 词:痰热清注射液  纳洛酮  慢性呼吸衰竭  肺性脑病  脑钠肽  超氧化物歧化酶  丙二醛
收稿时间:2016/7/23 0:00:00
修稿时间:2016/8/21 0:00:00

Clinical Efficacy of Tanreqing Injection Combined with Naloxone in the treatment of Elderly Patients with Chronic Respiratory Failure and Pulmonary Encephalopathy
Abstract:ABSTRACT Objective: To investigate the clinical efficacy of tanreqing injection combined with naloxone in the treatment of elderly patients with chronic respiratory failure and pulmonary encephalopath. Methods: A total of 60 cases with chronic respiratory failure and pulmonary encephalopathy from our hospital were collected and randomly divided into the experiment group and control group with 30 cases in each group. Patients in the control group were treated by tanreqing injection 20ml intravenous drip, 1 time / day; patients in the experiment group were treated on the basis of control group with naloxone injection 2 mg intravenous drip, 1 time/day. Both groups were treated for 4 cycles, a cycle with 7 days. After treatment, the arterial blood gas analysis results, serum BNP and SOD levels before and after the treatment and clinical efficacy were compared between two groups. Results: Compared with before treatment, the serum BNP and MDA levels of both groups were decreased after treatment , the serum SOD levels were increased (P<0.05), arterial blood gas analysis results showed PaO2 levels were increased, PaCO2 levels were decreased (P<0.05); compared with the control group, the total effective rate of experiment group was higher, the serum BNP and MDA levels were lower, the serum SOD levels were higher (P<0.05), arterial blood gas analysis results showed the PaO2 levels were higher, PaCO2 level were lower (P<0.05). Conclusion: Tanreqing injection combined with naloxone had a good clinical curative effect in the treatment of elderly patients with chronic respiratory failure and pulmonary encephalopathy, which might be related to the decrease of serum BNP and MDA levels, increase of the serum SOD level.
Keywords:Tanreqing injection  Naloxone  Chronic respiratory failure  Pulmonary encephalopathy  BNP  SOD  MDA
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号